South Australian Health and Medical Research Institute

Activities

Activities per year 1991 2016 2017 2018 2019 2020 2021 2025

• 562 Oral conference presentations and other invited talks
• 369 Publication peer-review
• 245 Invited Keynote and Plenary Presentations
• 186 Membership of committee
• 837 More
  • 178 Consumer Engagement
  • 137 Other
  • 112 Editorial Board Role
  • 86 Membership of network
  • 83 Membership of funding review panel
  • 51 Participation in conference
  • 47 Membership of board
  • 46 Examination
  • 40 Organising a conference
  • 25 Organising a workshop, seminar, course
  • 11 Participation in workshop, seminar, course
  • 10 Consultancy and providing expertise
  • 10 Newsletter
  • 1 Visiting an external academic institution

Activities per year

Search results

• Which Are the Best Tyrosine Kinase Inhibitors for Newly Diagnosed Chronic Myelogenous Leukemia?

  Hughes, T. (Speaker)

  30 May 2025 → 3 Jun 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Novartis Launch Meeting: 'Leading the CML Revolution’

  Hughes, T. (Invited speaker)

  10 Jun 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• 'Embarking on a new journey with Scemblix’ Meeting

  Hughes, T. (Speaker)

  23 Apr 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Characterization & Efficacy of Tern-701 in pre-clinical models of Chronic Myeloid Leukemia.

  Hughes, T. (Invited speaker)

  12 Jun 2025 → 15 Jun 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• New discoveries that will shape future therapies in Chronic Myeloid Leukemia

  Hughes, T. (Speaker)

  2 Mar 2025 → 29 Mar 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Debate 1 – CML - Asciminib first line?

  Hughes, T. (Invited speaker)

  7 Mar 2025 → 9 Mar 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• 'CML Elevate Clinic' Event

  Hughes, T. (Invited speaker)

  29 Apr 2025 → 30 Apr 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• CML Connect Meeting with Chang Gung Memorial Hospital Lankou - Novartis Taiwan

  Hughes, T. (Speaker)

  24 Apr 2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Omega-3 and Preterm Birth: From Clinical Trials to Real-World Implementation

  Best, K. (Speaker)

  2025

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Tyrosine kinase inhibitor-responsive chronic myeloid leukaemia is associated with reduced OXPHOS capacity and mtDNA mutations likely contribute to this.

  Pagani, I. (Speaker)

  15 May 2024 → 17 May 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• ASC4FIRST, a pivotal phase 3 study of asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS TKIs) in newly diagnosed patients (pts) with chronic myeloid leukemia (CML): Primary results.

  Hughes, T. (Invited speaker)

  31 May 2024 → 4 Jun 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Scientific Exchange: The Disconnect Between Basic and Clinical Research

  White, D. (Speaker)

  2 Sept 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Transcriptomic analysis reveals the intricacies of Ph+ ALL: Examining gene expression patterns and deletions in relation to patient prognosis.

  White, D. (Speaker)

  27 Sept 2024 → 29 Sept 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Embedding an Omega-3 Test-and-Treat Program into Routine Antenatal Care to Prevent Preterm Birth

  Best, K. (Speaker)

  2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• The PoppiE Study - A Decentralised Approach to Perinatal Research.

  Best, K. (Speaker)

  2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Clinical Spotlight Presentation - Chronic Myeloid Leukaemia: Next Challenges

  Hughes, T. (Speaker)

  4 Mar 2024 → 5 Mar 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Therapy-related myeloid neoplasm: when genetics collide with environment

  Hiwase, D. (Invited speaker)

  4 Mar 2024 → 6 Mar 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Healthcare of the Future

  White, D. (Keynote speaker)

  5 Jul 2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Omega-3 to Reduce Preterm Birth – from Clinical Trials to Implementation

  Best, K. (Speaker)

  2024

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Evaluating an Omega-3 Test-and-Treat Program, as Part of Routine Pregnancy Care, to Prevent Preterm Birth

  Northcott, C. (Speaker)

  15 Sept 2023

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Translating Research into Clinical Practice: Implementation of an Omega-3 Test-and-Treat Program into Routine Antenatal Care

  Northcott, C. (Speaker)

  30 Nov 2023

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Omega-3 Test-and-Treat Program

  Northcott, C. (Speaker)

  18 Aug 2023

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Resolving Unresolved Neurodevelopmental Disorders

  Gecz, J. (Invited speaker)

  2022

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• CEIH Improvement Showcase, Improvement Enabled by Technology

  Makrides, M. (Speaker)

  19 May 2022

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Translational Research Symposium

  Makrides, M. (Speaker)

  1 Jul 2022

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• PCDH19 clustering epilepsy, disorder of cellular mosaics.

  Gecz, J. (Invited speaker)

  2022

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Epi and Genetic Determinants of the Variability in CLinical Expressivity

  Gecz, J. (Invited speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Timing meals and macronutrients: impacts on insulin and clocks

  Heilbronn, L. (Invited speaker)

  11 Aug 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Time restricted eating – challenges in translation

  Heilbronn, L. (Invited speaker)

  20 Jul 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Mechanisms Underlying Bladder Sensation in Health and Disease

  Grundy, L. (Speaker)

  10 Sept 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Why good trials fail and other bumps in the road?

  Best, K. (Speaker)

  30 Jul 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• ESH INTERNATIONAL JOHN GOLDMAN RESEARCH AWARD 2019: PRESENTATION OF RESULTS. Sunday, October 10 from 13:00 to 13:25 CEST.

  Pagani, I. (Speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Partnerships for Impact: establishing and delivering responsive, integrated EBHC evidence and interventions in a pandemic

  Miller, C. (Invited speaker)

  19 May 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• COVID-19: A Public Health Response

  Miller, C. (Invited speaker)

  15 Feb 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• The Impact of Intermittent Fasting on Health, Aging, and Disease

  Heilbronn, L. (Invited speaker)

  21 Jun 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• 16th Troina Meeting on Genetics of Neurodevelopmental Disorders

  Gecz, J. (Invited speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Considerations for Genome Editing in Neurological Disorders

  Gecz, J. (Speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Genetics and Biology of neurodevelopmental disabilities.

  Gecz, J. (Invited speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• PCDH19 Clustering Epilepsy

  Gecz, J. (Keynote speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• COVID-19 and Obesity: implications for policy in Asia and Oceania

  Miller, C. (Invited speaker)

  6 Apr 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Pandemics & syndemics - COVID-19, NCDs and the drivers of health

  Miller, C. (Invited speaker)

  10 May 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Genetic Epilepsy Team Australia on Precision Medicine in Epilepsy

  Gecz, J. (Invited speaker)

  2021 → …

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Japan Paediatric Genetics Society Annual Scientific Meeting

  Gecz, J. (Keynote speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Circadian influences on weight and metabolic health

  Heilbronn, L. (Invited speaker)

  3 Sept 2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Targeting Oxidative phosphorylation to eradicate chronic myeloid leukaemia stem cells

  Pagani, I. (Speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• iCMLf Conversation: CML Highlights of EHA

  Pagani, I. (Speaker)

  2021

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• A systems immunology approach to investigate the influence of the gut microbiota on immune responses to vaccination

  Lynn, D. (Speaker)

  12 Nov 2020

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Variable clinical and molecular expressivity of PCDH19 X-linked Clustering Epilepsy, a complex disorder of cellular mosaics.

  Gecz, J. (Invited speaker)

  2020

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• The role of epiphenotyping in epilepsy

  Gecz, J. (Invited speaker)

  2020

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations

• Genomics and Aboriginal Health: Hope or Hype?

  Brown, A. (Speaker)

  23 Jan 2020

  Activity: Invited talks and oral presentations › Invited Keynote and Plenary Presentations